4586 — Medrx Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥3bn
- ¥2bn
- ¥258m
Annual cashflow statement for Medrx Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,107 | -1,058 | -1,109 | -930 | -803 |
| Depreciation | |||||
| Non-Cash Items | -37 | -5.97 | 3.47 | 1.6 | 2.04 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 102 | 80.4 | -13.9 | -30.9 | -41.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -985 | -924 | -1,073 | -914 | -803 |
| Capital Expenditures | -39.4 | -2.54 | -1.96 | -0.759 | -0.265 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 34.3 | — | — | — | -2.89 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.1 | -2.54 | -1.96 | -0.759 | -3.15 |
| Financing Cash Flow Items | 6.31 | 14.9 | 4.18 | 1.75 | 2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,394 | 816 | 356 | 1,639 | 1,067 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 402 | -109 | -710 | 727 | 257 |